HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideo Yagi Selected Research

Hideo Yagi Research Topics

Disease

20Thrombotic Thrombocytopenic Purpura
02/2024 - 01/2002
14Multiple Myeloma
05/2024 - 06/2014
6Thrombocytopenia (Thrombopenia)
11/2023 - 07/2005
6Neoplasms (Cancer)
01/2022 - 01/2004
5Thrombosis (Thrombus)
11/2020 - 02/2005
5Hemolytic-Uremic Syndrome
05/2011 - 01/2002
4Hemolytic Anemia
11/2023 - 07/2005
3Hemorrhage
01/2021 - 01/2002
3acquired Thrombotic thrombocytopenic purpura
11/2020 - 09/2002
3Thrombotic Microangiopathies
03/2012 - 12/2003
2Fever (Fevers)
01/2021 - 07/2005
2Renal Insufficiency (Renal Failure)
01/2021 - 07/2005
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2023
1Infections
12/2023
1Essential Thrombocythemia
01/2022
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2021
1Inflammation (Inflammations)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Enteritis
01/2021
1Ulcer
01/2021
1Skin Ulcer
01/2021
1Edema (Dropsy)
01/2021
1Disease Progression
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Multi-centric Castleman's Disease
01/2021
1Rare Diseases (Rare Disease)
10/2019
1Residual Neoplasm
11/2018
1HELLP Syndrome
09/2017
1Atrophy
08/2017
1Aortic Valve Stenosis (Aortic Stenosis)
10/2016
1Hematologic Neoplasms (Hematological Malignancy)
01/2016
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2012
1Connective Tissue Diseases (Connective Tissue Disease)
03/2012
1Neurologic Manifestations (Neurological Manifestations)
01/2012
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
11/2006
1Autoimmune Diseases (Autoimmune Disease)
01/2004
1Diarrhea
12/2002
1Disease Susceptibility (Diathesis)
01/2002

Drug/Important Bio-Agent (IBA)

16thiamine triphosphorate (TTP)IBA
11/2023 - 05/2002
7von Willebrand FactorIBA
02/2024 - 12/2003
6Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2015
6ADAMTS13 ProteinIBA
12/2003 - 01/2002
4Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2015
3AutoantibodiesIBA
01/2021 - 01/2002
3Bortezomib (Velcade)FDA Link
01/2017 - 06/2014
3AntigensIBA
10/2016 - 01/2007
2pomalidomideIBA
05/2024 - 05/2018
2elotuzumabIBA
03/2024 - 01/2023
2daratumumabIBA
03/2024 - 01/2022
2caplacizumabIBA
02/2024 - 11/2020
2SteroidsIBA
01/2021 - 01/2021
2Thalidomide (Thalomid)FDA Link
01/2017 - 01/2016
2EnzymesIBA
09/2002 - 01/2002
1isatuximabIBA
05/2024
1carfilzomibIBA
01/2022
1ixazomibIBA
04/2021
1YttriumIBA
02/2021
1Bendamustine HydrochlorideFDA Link
02/2021
1Rituximab (Mabthera)FDA Link
02/2021
1ibritumomab tiuxetan (Zevalin)FDA Link
02/2021
1Capsules (Microcapsules)IBA
01/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1Reticulin (Reticular Fiber)IBA
01/2021
1Alkaline PhosphataseIBA
01/2021
1RistocetinIBA
11/2020
1botrocetinIBA
11/2020
1ARC 1779IBA
11/2020
1Glycoproteins (Glycoprotein)IBA
11/2020
1Platelet Membrane GlycoproteinsIBA
11/2020
1antineoplaston A10 (A 10)IBA
11/2017
1Monoclonal AntibodiesIBA
11/2017
1lipopigmentsIBA
08/2017
1Drug CombinationsIBA
01/2017
1Melphalan (Alkeran)FDA LinkGeneric
01/2016
1Proteasome Endopeptidase Complex (Proteasome)IBA
06/2014
1Proteasome InhibitorsIBA
06/2014
1Fluorescent Dyes (Fluorescent Probes)IBA
09/2012
1Cilostazol (Pletal)FDA LinkGeneric
09/2012
1Tirofiban (Aggrastat)FDA Link
09/2012
1CollagenIBA
09/2012
1N 30IBA
06/2007
1Ticlopidine (Ticlid)FDA LinkGeneric
07/2005
1Rose BengalIBA
02/2005
1triphosphoric acid (triphosphate)IBA
02/2005
1Protein Isoforms (Isoforms)IBA
02/2005
1alpha-galactosylceramideIBA
02/2005
1Peptide Hydrolases (Proteases)FDA Link
12/2003
1Immunoglobulin G (IgG)IBA
12/2002
1Nonsense Codon (Nonsense Mutation)IBA
09/2002

Therapy/Procedure

9Therapeutics
11/2023 - 12/2002
3Drug Therapy (Chemotherapy)
12/2023 - 01/2021
3Stem Cell Transplantation
11/2021 - 01/2004
1Hematopoietic Stem Cell Transplantation
12/2023
1Radioimmunotherapy
02/2021
1Hematopoietic Stem Cell Mobilization
01/2017
1Liver Transplantation
12/2003
1Plasma Exchange
05/2002